MIA2 and cancer: Among these are proteins associated with inflammation (i.e., interleukin-37), physiological responses such as electrolyte secretion (i.e., calcium-activated chloride channel regulator 4), and cancers such as cutaneous T cell lymphoma (i.e., melanoma inhibitory activity protein 2).